摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3-chloro-5-hexyl-2,6-dihydroxyphenyl)(4,5-dichloropyrrol-3-yl)methanone | 491600-94-3

中文名称
——
中文别名
——
英文名称
(3-chloro-5-hexyl-2,6-dihydroxyphenyl)(4,5-dichloropyrrol-3-yl)methanone
英文别名
(3-Chloro-5-hexyl-2,6-dihydroxyphenyl)(4,5-dichloro-1H-pyrrol-3-yl)methanone;(3-chloro-5-hexyl-2,6-dihydroxyphenyl)-(4,5-dichloro-1H-pyrrol-3-yl)methanone
(3-chloro-5-hexyl-2,6-dihydroxyphenyl)(4,5-dichloropyrrol-3-yl)methanone化学式
CAS
491600-94-3
化学式
C17H18Cl3NO3
mdl
——
分子量
390.694
InChiKey
JCODZTWACRQCLZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    乙醇中≤20mg/ml;DMSO 中≤20mg/ml;二甲基甲酰胺中≤20mg/ml

计算性质

  • 辛醇/水分配系数(LogP):
    7.1
  • 重原子数:
    24
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    73.3
  • 氢给体数:
    3
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    (3-chloro-5-hexyl-2,6-dimethoxyphenyl)(4,5-dichloropyrrol-3-yl)methanone三溴化硼碳酸氢钠 作用下, 以 二氯甲烷 为溶剂, 以76%的产率得到(3-chloro-5-hexyl-2,6-dihydroxyphenyl)(4,5-dichloropyrrol-3-yl)methanone
    参考文献:
    名称:
    Revised Structure and Synthesis of Celastramycin A, A Potent Innate Immune Suppressor
    摘要:
    After searching for natural substances that regulate innate immunity using the ex vivo Drosophila culture system, a benzoyl pyrrole-type compound, celastramycin A, was identified and isolated as a potent suppressor. By synthesizing the previously reported structure 1 and another benzoyl pyrrole-type compound 2 reported in a Japanese patent, the correct structure of celastramycin A was confirmed to be 2. Compound 2 suppressed the production of IL-8 (IC50 0.06 mu g/mL) in human umbilical vein endothelial cells (HUVECs).
    DOI:
    10.1021/ol9002306
点击查看最新优质反应信息

文献信息

  • PROPHYLACTIC OR THERAPEUTIC AGENT FOR PULMONARY HYPERTENSION COMPRISING UNSATURATED 5-MEMBERED HETEROCYCLE-CONTAINING COMPOUND
    申请人:TOHOKU UNIVERSITY
    公开号:US20210299093A1
    公开(公告)日:2021-09-30
    The present invention provides a preventive or therapeutic agent for pulmonary hypertension, including a compound represented by the following formula (I) or a salt thereof: where: -A- represents —NH—, —S—, or —O—; R 1 and R 2 are identical to or different from each other, and each represent a hydrogen atom or an alkyl group; R 3 represents a hydrogen atom, a halogen atom, or an alkyl group; R 4 represents a hydrogen atom or an alkyl group; R 5 represents a hydrogen atom or an alkyl group; R 6 and R 7 are identical to or different each other, and each represent a hydrogen atom, a halogen atom, or an alkyl group; and R 6 and R 7 may form an unsaturated hydrocarbon six-membered ring together with a carbon atom to which R 6 is bonded and a carbon atom to which R 7 is bonded.
  • Revised Structure and Synthesis of Celastramycin A, A Potent Innate Immune Suppressor
    作者:Haruhisa Kikuchi、Mizuki Sekiya、Yasuhiro Katou、Kazunori Ueda、Takahiro Kabeya、Shoichiro Kurata、Yoshiteru Oshima
    DOI:10.1021/ol9002306
    日期:2009.4.16
    After searching for natural substances that regulate innate immunity using the ex vivo Drosophila culture system, a benzoyl pyrrole-type compound, celastramycin A, was identified and isolated as a potent suppressor. By synthesizing the previously reported structure 1 and another benzoyl pyrrole-type compound 2 reported in a Japanese patent, the correct structure of celastramycin A was confirmed to be 2. Compound 2 suppressed the production of IL-8 (IC50 0.06 mu g/mL) in human umbilical vein endothelial cells (HUVECs).
查看更多